vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and STEM, INC. (STEM). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $47.1M, roughly 1.8× STEM, INC.). iQSTEL Inc runs the higher net margin — -3.2% vs -33.9%, a 30.7% gap on every dollar of revenue. On growth, iQSTEL Inc posted the faster year-over-year revenue change (-14.9% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 28.0%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
IQST vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $47.1M |
| Net Profit | $-2.7M | $-16.0M |
| Gross Margin | 3.5% | 48.9% |
| Operating Margin | -2.9% | -17.7% |
| Net Margin | -3.2% | -33.9% |
| Revenue YoY | -14.9% | -15.6% |
| Net Profit YoY | -44.5% | 68.8% |
| EPS (diluted) | $-0.92 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $47.1M | ||
| Q3 25 | $102.9M | $38.2M | ||
| Q2 25 | $72.2M | $38.4M | ||
| Q1 25 | $57.6M | $32.5M | ||
| Q4 24 | $98.9M | $55.8M | ||
| Q3 24 | $54.2M | $29.3M | ||
| Q2 24 | $78.6M | $34.0M | ||
| Q1 24 | $51.4M | $25.5M |
| Q4 25 | $-2.7M | $-16.0M | ||
| Q3 25 | $-2.3M | $-23.8M | ||
| Q2 25 | $-2.3M | $202.5M | ||
| Q1 25 | $-1.1M | $-25.0M | ||
| Q4 24 | $-1.9M | $-51.1M | ||
| Q3 24 | $-773.0K | $-148.3M | ||
| Q2 24 | $-2.0M | $-582.3M | ||
| Q1 24 | $-580.2K | $-72.3M |
| Q4 25 | 3.5% | 48.9% | ||
| Q3 25 | 2.7% | 35.5% | ||
| Q2 25 | 2.6% | 33.4% | ||
| Q1 25 | 3.4% | 32.4% | ||
| Q4 24 | 2.7% | -4.4% | ||
| Q3 24 | 3.7% | 21.2% | ||
| Q2 24 | 2.8% | 27.6% | ||
| Q1 24 | 2.7% | -95.0% |
| Q4 25 | -2.9% | -17.7% | ||
| Q3 25 | -0.5% | -33.6% | ||
| Q2 25 | -0.9% | -34.8% | ||
| Q1 25 | -1.0% | -65.0% | ||
| Q4 24 | -0.3% | -84.4% | ||
| Q3 24 | -0.1% | -493.2% | ||
| Q2 24 | -0.4% | -1705.5% | ||
| Q1 24 | -0.4% | -267.0% |
| Q4 25 | -3.2% | -33.9% | ||
| Q3 25 | -2.3% | -62.2% | ||
| Q2 25 | -3.3% | 527.8% | ||
| Q1 25 | -2.0% | -76.9% | ||
| Q4 24 | -1.9% | -91.6% | ||
| Q3 24 | -1.4% | -506.3% | ||
| Q2 24 | -2.5% | -1712.6% | ||
| Q1 24 | -1.1% | -283.9% |
| Q4 25 | $-0.92 | $-4.40 | ||
| Q3 25 | $-0.68 | $-2.84 | ||
| Q2 25 | $-0.82 | $-1.79 | ||
| Q1 25 | $-0.44 | $-0.15 | ||
| Q4 24 | $-1.19 | $-15.29 | ||
| Q3 24 | $-0.40 | $-18.24 | ||
| Q2 24 | $-0.90 | $-71.81 | ||
| Q1 24 | $-0.37 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $48.9M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $16.3M | $-249.4M |
| Total Assets | $51.1M | $308.9M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $48.9M | ||
| Q3 25 | $2.3M | $43.1M | ||
| Q2 25 | $2.0M | $40.8M | ||
| Q1 25 | $1.1M | $58.6M | ||
| Q4 24 | $2.5M | $56.3M | ||
| Q3 24 | $2.1M | $75.4M | ||
| Q2 24 | $797.2K | $89.6M | ||
| Q1 24 | $2.7M | $112.8M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $3.5M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $194.0K | — |
| Q4 25 | $16.3M | $-249.4M | ||
| Q3 25 | $17.9M | $-235.7M | ||
| Q2 25 | $14.3M | $-214.1M | ||
| Q1 25 | $11.6M | $-417.5M | ||
| Q4 24 | $11.9M | $-398.4M | ||
| Q3 24 | $8.1M | $-344.1M | ||
| Q2 24 | $7.6M | $-203.2M | ||
| Q1 24 | $8.4M | $371.6M |
| Q4 25 | $51.1M | $308.9M | ||
| Q3 25 | $46.9M | $362.6M | ||
| Q2 25 | $51.4M | $379.2M | ||
| Q1 25 | $42.0M | $405.1M | ||
| Q4 24 | $79.0M | $437.4M | ||
| Q3 24 | $32.4M | $537.8M | ||
| Q2 24 | $30.0M | $691.5M | ||
| Q1 24 | $22.1M | $1.3B |
| Q4 25 | 0.25× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $8.2M |
| Free Cash FlowOCF − Capex | $-1.2M | — |
| FCF MarginFCF / Revenue | -1.5% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $8.2M | ||
| Q3 25 | $-953.0K | $11.4M | ||
| Q2 25 | $257.7K | $-21.3M | ||
| Q1 25 | $-1.9M | $8.5M | ||
| Q4 24 | $-403.7K | $-14.7M | ||
| Q3 24 | $625.0K | $-9.4M | ||
| Q2 24 | $-2.6M | $-11.9M | ||
| Q1 24 | $-536.9K | $-621.0K |
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-969.2K | — | ||
| Q2 25 | $211.7K | — | ||
| Q1 25 | $-2.0M | — | ||
| Q4 24 | $-421.3K | — | ||
| Q3 24 | $594.5K | — | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-608.5K | — |
| Q4 25 | -1.5% | — | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | -3.4% | — | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -1.2% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
STEM
Segment breakdown not available.
